GlobeNews Wire

Huws Gray Group Streamlines IT Operations Across 335 Locations, Saving 40+ Hours Monthly with ControlUp ONE Platform

LONDON, Oct. 01, 2025 (GLOBE NEWSWIRE) -- ControlUp, a global leader in Digital Employee Experience (DEX) management, today announced that…

6 months ago

YD Bio Limited Reports Unaudited Half Year 2025 Financial Results

September 30, 2025 17:25 ET  | Source: YD Bio Limited TAIWAN, Sept. 30, 2025 (GLOBE NEWSWIRE) -- YD Bio Limited…

6 months ago

The Beauty Health Company Names Pedro Malha President and Chief Executive Officer

Global Healthcare and Medical Device Executive with More Than 20 Years of Experience Assumes Role Effective October 1 Marla Beck…

6 months ago

Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

September 30, 2025 16:24 ET  | Source: Pyxis Oncology BOSTON, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq:…

6 months ago

The Eclipse Foundation Releases the 2025 Jakarta EE Developer Survey Report

The 8th annual report highlights Jakarta EE’s growing momentum, with the platform surpassing Spring as the leading choice for developers…

6 months ago

E-GetS Scales User Engagement Across SEA with EngageLabs Omnichannel AppPush & WhatsApp Business Solutions

SINGAPORE, Sept. 30, 2025 (GLOBE NEWSWIRE) -- EngageLab, a world-leading AI-powered omnichannel customer engagement solution provider, today announced the successful…

6 months ago

Aerospike Database 8.0 Wins 2025 SiliconANGLE TechForward Awards

MOUNTAIN VIEW, Calif., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Aerospike, Inc., today announced that Aerospike Database 8 has been named…

6 months ago

Nxera Pharma to Receive US$10 Million Milestone Payment from AbbVie under Collaboration Targeting Neurological Diseases

September 29, 2025 19:30 ET  | Source: Nxera Pharma Tokyo, Japan and Cambridge and London, UK, 30 September 2025 –…

6 months ago

Artelo Biosciences Announces Proposed Underwritten Public Offering

September 29, 2025 19:15 ET  | Source: Artelo Biosciences SOLANA BEACH, Calif., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences,…

6 months ago

NANOBIOTIX Announces Updated Phase 1 Results Continuing to Support JNJ-1900 (NBTXR3) Plus Anti-PD-1 as a Potential New 1L or 2L+ Option in Anti-PD-1 Nave or Resistant R/M-HNSCC

Treatment remained well-tolerated with consistent injection feasibility in 103 heavily pre-treated patients with R/M-HNSCC naïve or resistant to anti-PD-163% (26/41)…

6 months ago